印度亚热带地区毒动物致急性肾损伤的流行病学与结局
该回顾性研究纳入印度Shimla Indira Gandhi医学院医院2003年1月至2017年12月共15年间因毒动物致急性肾损伤(AKI)入院的181例患者,蛇咬伤(77.9%)与蜂蜇伤(19.9%)为主要病因。148例有临床资料者中,81.8%少尿,54.7%有血尿或红色/棕色尿,实验室异常包括贫血75%、白细胞增多75.7%、高钾血症35.8%、严重代谢性酸中毒46.6%、肝功能异常54.7%、溶血85.8%、横纹肌溶解65.5%。82.3%需透析,85.1%存活、14.9%死亡。死亡组白细胞计数、血清胆红素、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、肌酸激酶、乳酸脱氢酶显著更高,血清白蛋白显著更低;死亡组白细胞增多、高钾血症、代谢性酸中毒、肺炎/急性呼吸窘迫综合征(ARDS)、癫痫/脑病、需ICU支持及透析的比例显著更高。
要点
- 181例毒动物致AKI中蛇咬伤占77.9%、蜂蜇伤占19.9%,为两大主要病因。
- 82.3%患者需透析,总体死亡率14.9%(27/181),AKI严重程度高。
- 死亡组较存活组白细胞计数、血清胆红素、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、肌酸激酶、乳酸脱氢酶显著更高,血清白蛋白显著更低。
- 死亡组白细胞增多、高钾血症、代谢性酸中毒、肺炎/ARDS、癫痫/脑病、需ICU支持及透析的比例显著高于存活组。
- 148例有临床资料者中位到院时间为2天,81.8%少尿,54.7%有血尿或红色/棕色尿。
适用人群与场景
- 印度Shimla Indira Gandhi医学院医院2003年1月至2017年12月因毒动物致AKI入院的患者,共181例,平均年龄44±15.4岁,女性占54.1%。
红旗征与不能漏的情况
- 少尿(81.8%)、血尿或红色/棕色尿(54.7%)提示毒动物致AKI。
- 高钾血症(35.8%)、严重代谢性酸中毒(46.6%)为常见危及生命的实验室异常。
- 肺炎/ARDS(11.5%)、癫痫/脑病(10.8%)、胃肠道出血(9.5%)为主要并发症。
研究设计与关键结果
- 回顾性研究,181例毒动物致AKI,蛇咬伤77.9%、蜂蜇伤19.9%为主要病因。
- 148例有临床资料者中位到院时间2天,少尿81.8%,血尿或红色/棕色尿54.7%。
- 实验室异常:贫血75%、白细胞增多75.7%、高钾血症35.8%、严重代谢性酸中毒46.6%、肝功能异常54.7%、溶血85.8%、横纹肌溶解65.5%。
- 主要并发症:胃肠道出血9.5%、癫痫/脑病10.8%、肺炎/ARDS 11.5%。
- 82.3%需透析,154例(85.1%)存活,27例(14.9%)死亡。
- 死亡组较存活组白细胞计数、血清胆红素、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、肌酸激酶、乳酸脱氢酶显著更高,血清白蛋白显著更低。
- 死亡组白细胞增多、高钾血症、代谢性酸中毒、肺炎/ARDS、癫痫/脑病、需ICU支持及透析的比例显著更高。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 毒动物致AKI患者中蛇咬伤与蜂蜇伤为最常见病因,应据此评估暴露史。
- 该人群AKI严重,82.3%需透析,应评估透析指征与ICU支持需求。
- 死亡组白细胞计数、血清胆红素、天冬氨酸氨基转移酶、丙氨酸氨基转移酶、肌酸激酶、乳酸脱氢酶更高而血清白蛋白更低,提示这些指标与死亡相关;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To study the epidemiology and outcome of acute kidney injury (AKI) caused by venomous animals.
METHODS: A retrospective study of patients admitted at Indira Gandhi Medical College Hospital, Shimla, with AKI due to venomous animals over a period of 15 years (January 2003-December 2017). Medical records were evaluated for patient information on demographic factors, clinical characteristics, complications, and outcome. Outcomes of requirement for intensive care unit (ICU) support, treatment with dialysis, survival, and mortality were analyzed. The survival and non-survival groups were compared to see the difference in the demographic factors, laboratory results, clinical characteristics, and complications.
RESULTS: One hundred and eighty-one patients were diagnosed with AKI caused by venomous creatures. Mean age was 44 ± 15.4 years, and the majority (54.1%) was women. Snakebite (77.9%) and wasp stings (19.9%) were the leading causes of AKI. Clinical details were available in 148 patients. The median duration of arrival at hospital was two days. 81.8% had oliguria, and 54.7% had a history of hematuria or having passed red or brown colored urine. The hematological and biochemical laboratory abnormalities were as follows: anemia (75%), leukocytosis (75.7%), hyperkalemia (35.8%), severe metabolic acidosis (46.6%), hepatic dysfunction (54.7%), hemolysis (85.8%), and rhabdomyolysis (65.5%). Main complications were as follows: gastrointestinal bleed (9.5%), seizure/encephalopathy (10.8%), and pneumonia/acute respiratory distress syndrome (ARDS) (11.5%). 82.3% of the patients required dialysis. 154 (85.1%) patient survived, and 27 (14.9%) patients died. As compared to the survival group, the white blood cell count, serum bilirubin, aspartate aminotransferase, alanine aminotransferase, creatine kinase, and lactate dehydrogenase were significantly higher, and serum albumin levels were significantly lower in patients who died. The proportion of patients with leukocytosis, hyperkalemia, metabolic acidosis, pneumonia/ARDS, seizure/encephalopathy, need for ICU support, and dialysis was significantly higher in patients who died.
CONCLUSIONS: Snakebite and multiple Hymenoptera stings (bees and wasps) were the leading causes of AKI due to venomous animals. AKI was severe, a high proportion required dialysis, and the mortality was high.
参考来源
- Vikrant S, Jaryal A, Gupta D, et al. Epidemiology and outcome of acute kidney injury due to venomous animals from a subtropical region of India. Clin Toxicol (Phila). 2018. PMID: 30306815. doi:10.1080/15563650.2018.1513526
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。